Sign in

What researchers published on Pancreatic cancer

55,828 papers, newest first.

Showing 40 of 55,828

  • Reply to the Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • ASO Visual Abstract: Prognostic Impact of the Combined Use of CA19-9 and DUPAN-2 in Initially Unresectable Locally Advanced Pancreatic Adenocarcinoma.Annals of surgical oncology
  • High-Sensitivity Detection of Early Pancreatic Cancer Using a Structured Scoring System Among Clinically Selected Outpatients: A Nationwide Prospective Study.United European gastroenterology journal
  • Letter to the Editor: Evaluation of P-POSSUM Risk Scoring System in Prediction of Morbidity and Mortality after Pancreaticoduodenectomy.Chirurgia (Bucharest, Romania : 1990)
  • An asymmetric split-costimulatory MSLN.BBz/NKG2D.28 dual CAR-T design enhances activity against antigenically heterogeneous pancreatic cancer.Molecular therapy. Oncology
  • Phase I dose-escalation study of stereotactic body radiotherapy with elective nodal irradiation for borderline resectable and unresectable locally advanced pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • ACSL5 suppresses pancreatic cancer progression and gemcitabine resistance by regulating n-6 docosapentaenoic acid metabolism.Cell death & disease
  • ReviewTumo​r-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
  • ReviewUnifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.Molecular cancer
  • Review[Research progress of irreversible electroporation for pancreatic cancer].Zhonghua nei ke za zhi
  • Bioabsorbable spacer-assisted high-dose proton beam therapy for unresectable locally advanced pancreatic cancer of the body or tail: a feasibility and safety study.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Schisandrin B Suppresses Pancreatic Ductal Adenocarcinoma Through EGFR/AKT/mTOR Signaling and Mitochondrial Dysfunction.International journal of molecular sciences
  • ReviewSynergizing Against RAS: The Evolving Landscape of Targeted Combinations in Pancreatic Cancer.Cancers
  • Activity of Fluoro-Substituted 3,5-Di[(E)-Benzylidene]piperidin-4-Ones with N-Arylsulfonyl Appendages Against KRAS-Mutant Pancreatic Ductal Adenocarcinoma Cells.International journal of molecular sciences
  • ReviewCirculating Tumor DNA Across the Patient Journey in Pancreatic Cancer: From Molecular Profiling to Dynamic Disease Monitoring.Cancers
  • ReviewTreatment Strategies and Future Directions for Locally Advanced Pancreatic Cancer.Cancers
  • Yellow, Red, and Black Lepidium meyenii Preparations Differentially Modulate Doxorubicin Response and Lipid Metabolism-Related Changes in Pancreatic Cancer Cells.Molecules (Basel, Switzerland)
  • Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy.Cancers
  • ReviewThe Association Between Asthma and Pancreatic Cancer: A Systematic Review.Cancers
  • OTI1H1-Defined MAGEA3-Directed Immunoreactivity and Survival in Pancreatic Ductal Adenocarcinoma: A Single-Center Study.Journal of clinical medicine
  • Cellularity Improvement of EUS-FNB Specimens for Pancreatic Adenocarcinoma Using a Cell-Capturing Scaffold.Journal of clinical medicine
  • Tissue miR-143 and miR-29b Expression as Prognostic Biomarkers in Patients with Resected Pancreatic Ductal Adenocarcinoma Receiving Adjuvant Chemotherapy.Diagnostics (Basel, Switzerland)
  • The Cholecystokinin-B Receptor as a Candidate Diagnostic Biomarker and Translational Target for Precision Oncology in Pancreatic Cancer.Cancers
  • Kynureninase Is a Prognostic Biomarker of Poor Survival and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.International journal of molecular sciences
  • Targeting ELF3 with Biomimetic Nanotherapy Sensitizes PDAC to Gemcitabine via GSDME-mediated Pyroptosis.Pharmacological research
  • LncRNA signatures associated with exhausted CD8⁺T cells for assessing the immune microenvironment and drug sensitivity in pancreatic adenocarcinoma.Neoplasia (New York, N.Y.)
  • Explainable artificial intelligence identifies circulating microRNA candidate biomarkers for liquid biopsy-based pancreatic cancer detection.Frontiers in artificial intelligence
  • Simple Algorithm for Blood Morphology Analysis (SAMBA): An Artificial Intelligence-Assisted Approach to Identify Peripheral Blood Phenotypes in a Cohort of Patients with Pancreatic Ductal Adenocarcinoma (PDAC).Cancers
  • ReviewFood Environment, Food Access, and Disparities in Pancreatic Cancer Outcomes: A Narrative Review of Evidence Gaps and Future Directions.Nutrients
  • ReviewPeriodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.Journal of oral microbiology
  • ReviewChanging Course: Semaphorins and Plexins as Novel Therapeutic Opportunities and Key Regulators of Pancreatic Cancer Microenvironment.International journal of molecular sciences
  • Hydrophobic ion pairing enabled self-nanoemulsifying niclosamide for pancreatic cancer: improved drug loading and kinetic solubility.International journal of pharmaceutics
  • Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions.Current cancer drug targets
  • Depletion of Endogenous IL-18 Suppresses Pancreatic Cancer Progression, Reprograms the Tumor Microenvironment, and Enhances KRAS Inhibitor Efficacy.Gastroenterology
  • PRMT1 blockade reverts resistance to KRAS (G12C) inhibition through modulating ferroptosis signalling.International journal of oncology
  • A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.HPB : the official journal of the International Hepato Pancreato Biliary Association
  • Radical antegrade modular pancreatosplenectomy versus conventional distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma: a multicenter propensity score-matched analysis.Annals of surgical treatment and research
  • ReviewImmune cell metabolic reprogramming in pancreatic cancer: roles in tumor progression and therapeutic strategies.Frontiers in immunology
  • Case reportRecurrent Multi-territory Thromboembolism As the Initial Presentation of Pancreatic Adenocarcinoma and Suspected Nonbacterial Thrombotic Endocarditis.Cureus
  • Clinical Impact in Pancreatic Cancer Trials: Time to Raise the Bar.Annals of surgery